Use of IGF-I for the treatment of kidney disorders

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3800

Patent

active

059858303

ABSTRACT:
In accordance with the present invention, there are provided methods for the treatment of polycystic kidney disease and related indications in mammals, employing IGF-I as the active agent. In accordance with another embodiment of the present invention, it has been discovered that IGF-I is an effective agent for the treatment of renal dysplasias and/or renal hypoplasias in mammals. In accordance with yet another embodiment of the present invention, it has been discovered that IGF-I is an effective agent for enhancing glomerular development in mammals. In accordance with still another embodiment of the present invention, it has been discovered that IGF-I is an effective agent for enhancing kidney development in mammals suffering from chronic organ injury.

REFERENCES:
patent: 5565428 (1996-10-01), Clark et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Use of IGF-I for the treatment of kidney disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of IGF-I for the treatment of kidney disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of IGF-I for the treatment of kidney disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1324753

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.